Welcome: Alexandra Koumoutsi
New Head of the Microbial Automation and Culturomics Core Facility discusses her career, her goals for the facility, and her early inspirations.
PEOPLE & PERSPECTIVES2024
people-perspectives
EMBL ARISE2 programme receives EC funding
The programme will advance excellence in research infrastructure management and technology development.
EMBL ANNOUNCEMENTS2024
embl-announcements
Leveraging expertise across EMBL services
A scientific workshop on flow cytometry was organised at EMBL Rome, taking advantage of the presence of the Advanced Mobile Laboratory, the biggest unit of EMBL’s mobile lab fleet.
CONNECTIONS2024
connections
Proteomics: a different lens for precision medicine
The dynamic world of proteomics is shaping the future of personalised medicine, but some obstacles stand in the way
SCIENCE & TECHNOLOGY2024
perspectivesscience-technology
Embracing the genome sequencing revolution
EMBL’s Genomics Core Facility provides end-to-end support to researchers across Europe and beyond and stands at the forefront of scientific breakthroughs.
EMBLetc2023
We are EMBL: Gerald Pfister on scientific support and field work
Gerald Pfister, Head of the Flow Cytometry Facility at EMBL Rome, talks about his private and professional passions and a return to his roots as part of the TREC project.
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectives
Bringing scientific services together ‘2RISE’
An upcoming EMBL-led infrastructure management training will help formalise information exchange in the Rhine-Neckar region to widen access to technology and scientific services for members of the Health + Life Science Alliance.
CONNECTIONS2023
connectionsevents
We are EMBL: Adriana Castillo Caballero on multicultural science and creativity
Adriana Castillo Caballero talks about her curiosity-driven career, the importance of the people in her life, and her dreams for the future
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectives
EMBL welcomes first generation of ARISE fellows
Participating researchers will lead projects to develop novel technologies for better science.
LAB MATTERS2022
lab-matters
A new era for European molecular biology
EMBL announces details about its next programme, ‘Molecules to Ecosystems’. It will guide studying life across scales and in context with changing environments.
EMBL ANNOUNCEMENTSLAB MATTERS2022
announcementsembl-announcementslab-matters
EMBL experimental services enable European researchers to tackle global societal challenges
Independent impact review finds EMBL experimental services are ‘critical’ for research and endorses EMBL as a world-class service provider for academia and industry.
LAB MATTERSSCIENCE & TECHNOLOGY2021
lab-mattersscience-technology
Analysis and sorting with flow cytometry
A technology around since the ‘60s, flow cytometry has increasing applications. New leadership at EMBL’s flow cytometry facilities is looking to ease use, expand training, and encourage more collaboration.
LAB MATTERSSCIENCE & TECHNOLOGY2021
lab-mattersscience-technology
A cellular atlas of an entire worm
EMBL scientists and colleagues have developed an interactive atlas of the entire marine worm Platynereis dumerilii in its larval stage. The PlatyBrowser resource combines high-resolution gene expression data with volume electron microscopy images.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
The secret life of baby octopuses
Some of the most amazing creatures live in the deep blue sea. The Mesoscopic Imaging Facility (MIF) at EMBL Barcelona was recently involved in studying one unique feature of the octopus: the ephemeral structures on the surface of their skin called Kölliker’s organs.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Common medications accumulate in gut bacteria
A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
A flip book for biological systems
In the Mesoscopic Imaging Facility (MIF) at EMBL Barcelona, researchers study the details of biological systems in the context of organs, body parts, or entire organisms. This image shows OPTiSPIM1, one of the custom light-sheet microscope setups available at the facility.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
New insights into Salmonella’s survival strategies
Research in the Typas group uncovers new details of the strategies Salmonella uses to survive in infected cells.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
New life science Imaging Centre preparing for user access
The EMBL Imaging Centre is preparing for external user access, after an on-time and on-budget build and handover to the science team.
CONNECTIONSLAB MATTERS2021
connectionslab-matters
Starlet sea anemone
EMBL PhD student Anniek Stokkermans captured this side view of a Nematostella vectensis larva during this transition, using instrumentation in the Advanced Light Microscopy Facility at EMBL Heidelberg.
SCIENCE & TECHNOLOGY2021
picture-of-the-weekscience-technology
Dream team
At EMBL, we have many dream teams – groups of individuals who support each other, innovate, and work together. One of those dream teams bridges two core facilities at EMBL Rome.
SCIENCE & TECHNOLOGY2021
picture-of-the-weekscience-technology
Finding coronavirus’s helper proteins
A team of EMBL scientists and colleagues have analysed how the novel coronavirus affects proteins in human cells. They identified several human proteins as potential drug targets to prevent viral replication.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Cell under attack
It’s almost a year since the coronavirus outbreak was declared a pandemic, affecting all our lives. While the virus continues its grip on the world, scientists are understanding it better and better, increasing our knowledge about it and opening up new ways to fight it.
SCIENCE & TECHNOLOGY2021
picture-of-the-weekscience-technology
Chan Zuckerberg Initiative recognises EMBL scientists
The Chan Zuckerberg Initiative has recognised four EMBL researchers with their most recent awards, showing how tech trailblazers are integral to advancing science and medicine.
EMBL ANNOUNCEMENTSLAB MATTERS2020
embl-announcementslab-matters
Replication cycle of SARS-CoV-2 in 3D
Researchers have studied SARS-CoV-2 replication in cells and obtained detailed insights into the alterations induced in infected cells. This information is essential to guide the development of urgently needed therapeutic strategies for suppressing viral replication and induced pathology.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
ARISE fellowship programme readying for applications
Ever-evolving technology and related budgetary, regulatory, and management challenges prompted EMBL to establish its new ARISE fellowship programme, which begins accepting applicants in December.
LAB MATTERS2020
lab-matters
Beyond the lens – microscopy at EMBL Rome
Research facilities play a crucial role in the advancement of science by supporting scientists with specialised expertise and state-of-the-art equipment. The Microscopy Facility at EMBL Rome exemplifies this role by making a wide variety of light microscopy technologies available to its researchers…
LAB MATTERSSCIENCE & TECHNOLOGY2020
lab-mattersscience-technology
Level up!
ARISE fellowships to offer first-ever comprehensive training for bioscience infrastructure operations
LAB MATTERS2020
lab-matters
Helping to scale up coronavirus testing
Scientists at EMBL Heidelberg are contributing their expertise in a community effort to develop large-scale testing methods for coronavirus. Their goal is to increase the capacity and speed of testing, which is crucial for containing the pandemic.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Producing proteins for coronavirus research
The Protein Expression and Purification Core Facility at EMBL Heidelberg will produce proteins for several coronavirus-related research projects, to assist the development of new strategies to fight the virus.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
EMBL shares expertise with four European institutes
Three international teams involving EMBL Heidelberg have been granted funding from the European Commission for three Twinning projects with institutes in Portugal and the Czech Republic.
CONNECTIONSLAB MATTERS2020
connectionslab-matters
Finding your way around Platynereis dumerilii
EMBL researchers combine multiple datasets to develop expandable atlas of an entire animal
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Engineering bacteria to fight diabetes
EMBL’s Genomics Core Facility supports students participating in the annual iGEM competition.
SCIENCE & TECHNOLOGY2019
sciencescience-technology
New Directors and Associate Directors
Promotions for Anne Ephrussi, Rainer Pepperkok, Paul Flicek and Jo McEntyre
EMBL ANNOUNCEMENTSLAB MATTERS2019
embl-announcementslab-matters
CTLS: a professional association for core facilities
Core Technologies in Life Sciences (CTLS) association will be key resource for facility professionals
SCIENCE & TECHNOLOGY2016
sciencescience-technology
Welcome: Kim Remans
"We’re open! We’re open to working with everybody, we’re open to new things."
LAB MATTERSPEOPLE & PERSPECTIVES2016
lab-matterspeople-perspectives
Event gets to the core of research
Find out what’s in store at the 2016 Core Technologies for the Life Sciences meeting.
CONNECTIONS2015
connectionsevents
Welcome: Malte Paulsen
"There’s nothing nicer than seeing a user leave the facility happy"
LAB MATTERSPEOPLE & PERSPECTIVES2015
lab-matterspeople-perspectives
No results found